 CHERRY HILL, N.J., Aug. 31, 2022 GLOBE NEWSWIRE -- Vyant Bio, Inc. Vyant Bio or Company Nasdaq: VYNT is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Companys proprietary central nervous system CNS drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. Today, Vyant Bio announced that it will be presenting at the H.C. Wainwright 24th Annual Global Investment Conference. The event is being held from September 12-14, 2022. Registered attendees can access the recorded presentation on-demand 24x7 for 90 days. 